Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 43 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Brukom Farma from Sint-Pieters-Leeuw, company number BE0885958606, closed financial year 2025 with a result of € 94,026 after tax. For that financial year Brukom Farma recorded a gross margin of € 129,721 and equity of € 318,468. Compared with financial year 2024, the result moved from € 102,241 to € 94,026. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 318,468
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 94,026
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 47,598
▲ 8% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 94,023 paid out
100 % of the profit went to the shareholders, mostly to GeDP PHARMA (50 % of the shares). That is where the money ends up.
People and assets in 2025
€ 472
▼ 31% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 200,919
▼ 13% vs 2024
€ 30,644 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 169,997
▲ 69% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 80,608 | € 101,777 | € 139,350 | € 129,721 | ▼ 7% |
| Profit after taxes | € -13,167 | € 35,131 | € 102,241 | € 94,026 | ▼ 8% |
| Equity | € 155,401 | € 318,642 | € 318,465 | € 318,468 | |
| Total debts | € 655,231 | € 535,661 | € 515,915 | € 527,906 | ▲ 2% |
| Cash | € 86,451 | € 68,123 | € 43,980 | € 47,598 | ▲ 8% |
| Land & buildings | - | € 583,583 | € 556,416 | € 529,249 | ▼ 5% |
| Retained profit | € 143,001 | € 146,242 | € 146,065 | € 146,068 | |
| Dividend | € 0 | € 31,890 | € 102,417 | € 94,023 | ▼ 8% |
| Bank debt | € 289,589 | € 260,560 | € 231,015 | € 200,919 | ▼ 13% |
| Balance sheet total | € 810,632 | € 854,302 | € 834,380 | € 846,373 | ▲ 1% |
| Employees (FTE) | 1 | 0.5 | 0 | - |
Key figures of Brukom Farma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Brukom Farma?
What happened at Brukom Farma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 94,026 (▼ 8% vs 2024). Source: NBB ↗
- GeDP Pharma BV became a director. NBB
- Ter Beemd BV became a director. NBB
- New establishment in Sint-Pieters-Leeuw. KBO
- Start of the company according to the CBE. KBO
In short
From € 13,167 loss in 2022 to € 94,026 profit in 2025.
Paid € 262 in corporate taxes since 2022.
Best year ever: 2024, with € 102,241 profit.
On average € 80,600 of value added per employee in 2022.
A new publication or filing at Brukom Farma? We notify you, reason included.
Follow Brukom FarmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of GeDP PHARMA, TER BEEMD comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Brukom FarmaBehind Brukom Farma are Ter Beemd BV and GeDP Pharma BV. The shares are held by GeDP PHARMA (50%) and TER BEEMD (50%).
Directors
According to the 2025 annual accounts
since 2020
Director · represented by Depoorter Géraldine
since 2023
Shareholders
50%
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Bergensesteenweg 735
1600 Sint-Pieters-Leeuw
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0885.958.606
- VAT number
- BE 0885.958.606
- Registered office
- Bergensesteenweg 735, 1600 Sint-Pieters-Leeuw
- Names & denominations
- Brukom Farma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 December 2006
- Peppol
- Active · Active since 23 Mar 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Activiteiten van holdings
Markt- en opinieonderzoek
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Handel in eigen onroerend goed
Managementactiviteiten van holdings
Handel in onroerend goed
+4